自然植物化学物质将M2逆转为M1巨细胞:一种新的替代莱什曼病治疗方法
Aditya Mohanty1, Vasu Vekariya1, Shivani Yadav1
1Immunology Lab, Biotechnology & Bioengineering, Indian Institute of Advanced Research, Gandhinagar, Gujarat, 382426, India.
Microbial pathogenesis
|January 25, 2025
概括
植物化学物质通过调节巨细胞免疫反应,显示出治疗莱什曼病的前景. 它们激活M1巨细胞并影响细胞因子分泌,为目前的治疗提供了潜在的替代方案.
科学领域:
- 寄生虫学的寄生虫学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 莱什曼病是一种重要的热带寄生虫病,由沙传播.
- 疾病的进展受宿主免疫反应和巨细胞两极分化 (M1与M2) 的影响.
- M1巨细胞与寄生虫作斗争,而M2巨细胞支持其生存.
研究的目的:
- 识别具有免疫调节性质的新型植物化学物质,用于莱什曼病治疗.
- 探索植物化学物质如何影响巨细胞极化和细胞因子分泌以产生抗莱什曼效应.
- 调查植物化学作用对Leishmania的直接和间接机制.
主要方法:
- 对莱什曼病中植物化学物质和巨细胞免疫调节研究的文献综述.
- 分析植物化学物质如何影响M1和M2巨细胞两极分化.
- 检查植物化学品对M1和M2相关的细胞因子概况的影响.
主要成果:
- 植物化学物质通过反应性氧物种 (ROS) 生产和M1巨细胞激活表现出抗莱什曼的活性.
- 植物化学物质调节M1/M2相关的细胞因子,影响整体免疫反应.
- 植物化学物质对巨细胞活动和细胞因子概况的观察效应.
结论:
- 植物化学物质由于其免疫调节作用,为利什曼病治疗提供了一个有前途的途径.
- 有针对性的输送策略可以提高植物化学品的疗效.
- 植物化学物质为克服现有莱什曼病药物的局限性提供了一个可行的替代品.
相关概念视频
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...